Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial
Recruitment status was: Recruiting
The purpose of our randomized controlled trial is to determine whether mailed educational reminders would increase fecal occult blood test (FOBT) card return rates and, therefore, improve patient compliance with colonrectal cancer (CRC) screening.
We will conduct a randomized, controlled trial to evaluate the hypothesis that compliance to FOBT referrals is at least 10% greater among patients who receive mailed educational reminders on the importance of CRC screening. The study will be conducted in Veteran Affairs Medical Center and surrounding VA clinics in San Diego.
|Study Design:||Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double Blind (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Screening
|Official Title:||Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial|
- Our primary outcome is FOBT card return rate [ Time Frame: 6 months ]
- Predictors of Non-compliance to fecal occult blood testing [ Time Frame: 6 months ]
|Study Start Date:||June 2007|
|Estimated Study Completion Date:||October 2007|
400 patients will be given a mailed educational reminder 10 days after picking up their FOBT cards from the VA laboratory.
Other: Mailed Educational Reminder
1 page educational reminder that reminds the patient to return their FOBT cards back to the VA laboratory. In addition, it also contains reasons why colon cancer screening is important.
No Intervention: 2
400 patients will not receive a mailed educational reminder to return their FOBT cards after they have picked up the FOBT cards from the VA laboratory
Please refer to this study by its ClinicalTrials.gov identifier: NCT00534053
|Contact: Jeffrey K Lee, B.A.||email@example.com|
|United States, California|
|Veteran Affairs Medical Center San Diego||Recruiting|
|San Diego, California, United States, 92161|
|Principal Investigator: Samuel B Ho, M.D.|
|Principal Investigator:||Samuel B Ho, M.D.||UCSD, VA San Diego|